Development and validation of novel interpretable survival prediction models based on drug exposures for severe heart failure during vulnerable period-Reference-Cited by-同舟云学术

Development and validation of novel interpretable survival prediction models based on drug exposures for severe heart failure during vulnerable period

Published:2024-08-06 Issue:1 Volume:22 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Guo Yu,Yu Fang,Jiang Fang-Fang,Yin Sun-Jun,Jiang Meng-Han,Li Ya-Jia,Yang Hai-Ying,Chen Li-Rong,Cai Wen-Ke,He Gong-Hao^ORCID

Funder

the Applied Basic Research Program Yunnan Province of China

the National Science Foundation of China

the 2024 Young and Middle-aged Academic and Technical Leaders Reserve Talent Project of Yunnan Province

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12967-024-05544-6.pdf

Reference43 articles.

1. Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28(15):1682–90. https://doi.org/10.1093/eurjpc/zwaa147.

2. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–33. https://doi.org/10.1016/j.jacc.2013.11.053.

3. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171(3):368–76. https://doi.org/10.1016/j.ijcard.2013.12.028.

4. Metkus TS, Lindsley J, Fair L, Riley S, Berry S, Sahetya S, et al. Quality of heart failure care in the Intensive Care Unit. J Card Fail. 2021;27(10):1111–25. https://doi.org/10.1016/j.cardfail.2021.08.001.

5. Van Esbroeck ACM, Varga ZV, Di X, van Rooden EJ, Tóth VE, Onódi Z, et al. Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system. Pharmacol Res. 2020;151:104578. https://doi.org/10.1016/j.phrs.2019.104578.